PROVIDER PROFILE · NPI 1063503449
Michael BelgardPA
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
1,008
Beneficiaries
—
Total drug cost
$76K
Distinct drugs
39
Brand share
20.2%
Top prescribed drugs
Tramadol Hcl73 claims
Amlodipine Besylate68 claims
Atorvastatin Calcium59 claims
Gabapentin58 claims
Pantoprazole Sodium51 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (2)
Home health agency
Hospital
REFERRAL NETWORK
Where Michael Belgard's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 5 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| HEALTH OPPORTUNITIES FOR THE PEOPLE OF EAST TEXAS, INC. | 23 | 52 |
| Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX | 13 | 29 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| HEALTH OPPORTUNITIES FOR THE PEOPLE OF EAST TEXAS, INC. | 77 | 171 |
| TH HEALTHCARE, LTD | 16 | 45 |
| Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX | 12 | 18 |
| Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Irving, TX | 12 | 19 |
| LOCAL PORTABLE IMAGING LLC | 11 | 16 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE